Clinical trials are becoming more complex, with sites spread further across multiple regions, placing a higher burden on Sponsors for pharmacovigilance regulatory compliance. If you are an early-stage drug development Sponsor or work with one, please attend today's webinar or request a copy of the recording to explore what constitutes a compliant pharmacovigilance program, learn of considerations as the new therapy progresses through key milestones, and understand the proper requirements to make informed decisions. It starts at 11AM EST! Last minute registration is still available here: https://hubs.li/Q02G9frG0 #OneMMS #DrugDevelopment #PV #Pharmacovigilance #DrugSafety #Pharmaceuticals
MMS’ Post
More Relevant Posts
-
Check out our Pharmacovigilance offerings and let me know if you would like to discuss further #pharmacovigilance #clinicaltrials #postmarket
Our pharmacovigilance team supports the safety of our clients’ therapies throughout the clinical development and regulatory approval process— and their life on the market. Learn more 👇 https://bit.ly/3wQByKA #pharmacovigilance #ClinicalDevelopment #RegulatoryApproval
To view or add a comment, sign in
-
Account Development Specialist II - Connecting with Biopharmaceutical Sponsors to support Clinical Advancement and Regulatory Approval
From clinical development to regulatory approval and beyond, my pharmacovigilance colleagues at Veristat are dedicated to safeguarding the safety of our clients' therapies. Discover how Veristat can support your product's journey to and into the market > https://lnkd.in/gSrumpq9 Wanna know more? Reach out! #pharmacovigilance #ClinicalTrials #Veristat
Veristat | Pharmacovigilance and Medical Information Services
veristat.com
To view or add a comment, sign in
-
The objectives of US-Post-marketing Adverse Drug Experience (PADE) Compliance Program are to monitor industry compliance with post-marketing safety laws and regulations for human drugs and therapeutic biologics and to ensure that accurate, reliable, and timely safety data are submitted correctly to the FDA, thus making it critical for #Drug #Safety. Join us on Aug 14 for the first webinar on Post-marketing Adverse Drug Experience (PADE) Inspection Series. Register with us as our expert panel guides you on how to Manage PADE Inspections, with a focus on USFDA requirements. Save your spot for the webinar and register now: https://lnkd.in/gkNFJpQ4 #drugtrials #clinicaltrials #Webinar #Soterius #SignalDetection #drugsafety #clinicalsafety #clinicalresearch #LifeSciences #pharmacovigilance #pv #pharmaceuticals #pharmacy #soterius #adverseevent #liverinjury
To view or add a comment, sign in
-
-
General Manager - Life Sciences @ Terrapinn Americas | Drug Safety & Pharmacovigilance | Orphan Drugs | AMR | Disease Prevention | Future Labs Live
Starting from January 16, FDA began accepting electronic submissions of both expedited and non-expedited #postmarketing individual case #safety reports (ICSRs) for human drugs and biological products. Check out below report for more details. World Drug Safety Congress Americas #adverseevents #pharmacovigilance #icsr
FDA Adverse Events Reporting System
fda.gov
To view or add a comment, sign in
-
Ensuring drug safety is our top priority. 🛡️💊 At the upcoming Pharmacovigilance World Conference, we invite all stakeholders—pharmaceutical companies, healthcare professionals, regulators, and patients—to come together in the pursuit of safer medications and improved patient outcomes. Together, we will explore innovative solutions and best practices to enhance drug safety. Join us as we collaborate, share knowledge, and drive advancements in pharmacovigilance. Let’s unite for a safer world. Register now and be part of the change: https://lnkd.in/gQFGZvY8 #Pharmacovigilance #DrugSafety #PharmacovigilanceWorld #Healthcare #PatientSafety #Pharma #Pharmaceuticals #SafetyFirst #HealthTech #Conference2024 #DrugSafety #PV #QPPV #RegulatoryAffairs #PostAuthorization #SafetyManagement #SafetySignals #RiskManagement #SignalDetection #PharmacovigilanceOutsourcing #PatientCentric #PatientSafety #PVSystem #ChatGPT #ArtificialIntelligence #QualityAndCompliance #Automation #AdverseReaction #MedicalDeviceSafety #NLP #PharmacovigilanceConference
To view or add a comment, sign in
-
-
#Pharmacovigilance is a crucial part of #clinicalresearch as it ensures the safety and effectiveness of investigational drugs. Innovative technologies such as #AI has a lot of potential to greatly enhance pharmacovigilance practices by transforming drug safety monitoring. Swipe left to learn more. Check out how we can help your trials: https://bit.ly/3V0H5bg #ClinicalTrials #LifeSciences #ArtificialIntelligence #DrugSafety
To view or add a comment, sign in
-
Regulatory Intelligence 101: Navigating the Labyrinth of Drug Regulations in the USA For anyone involved in the pharmaceutical industry in the United States, Regulatory Intelligence serves as the compass through the intricate landscape of drug regulations. From FDA guidelines to compliance standards, staying informed is the key to navigating the regulatory labyrinth successfully. Join us at booth 101 to gain insights into latest regulatory updates – a fundamental aspect of drug development and commercialization. Discover how a comprehensive understanding of regulatory requirements can not only ensure compliance but also streamline the pathway to bringing safe and effective medications to the public. GRIP is one-of-a-kind subscription service consisting of a comprehensive collection, 160 countries and counting, of global requirements, that have been collected and analyzed by our pharmacovigilance experts. When GRIP is used within Insife’s PROHALO system, the intelligence gathered is linked automatically to other modules and the new rules, once verified and accepted by each GRIP member organization, can automate the submission process. #thedrugsafetyexperts #DIA #conference #PV #riskstrategy #pharmacovigilance #pharma #clinicalsafety #regulatoryintelligence
To view or add a comment, sign in
-
-
From Pharmacy to Pharmacovigilance The world of pharmaceuticals has undergone a dramatic evolution over the past century. This transformation is marked by significant advancements in drug discovery, development, and distribution. However, alongside these advancements comes an increased responsibility to ensure drug safety. This is where the field of pharmacovigilance (PV) comes into play. Transitioning from traditional pharmacy roles to pharmacovigilance is becoming increasingly common, as professionals seek to engage more deeply with the safety and efficacy of medications. This blog explores this journey from pharmacy to pharmacovigilance, highlighting the importance, challenges, and future prospects of this vital domain. Read the complete post at https://lnkd.in/gRQFE67v #pharmacovigilance #argussafety #drugsafety #signaldetection
To view or add a comment, sign in
-
-
A big thank you to RxConnect Pk for the opportunity to attend the insightful webinar on Pharmacovigilance: Adverse Drug reactions and safety signals 12.0. The session was truly enlightening, highlighting the critical importance of understanding drug interactions and their potential impact on patient safety. This knowledge is invaluable as I continue to develop my skills in the pharmaceutical industry. Looking forward to applying what I've learned to ensure safer and more effective patient care! #Pharmacovigilance #DrugSafety #PharmaceuticalIndustry #ContinuousLearning
To view or add a comment, sign in
-